Van Loon says that oncologists need further research into how often and for how long patients with gastrointestinal cancers should be monitored.
Katherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Brahmer Considers First-Line Immunotherapy Options in Metastatic NSCLC
February 17th 2025During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON trials of immunotherapy in patients with metastatic non–small cell lung cancer.
Read More